Join the club for FREE to access the whole archive and other member benefits.

Lorenz Hofbauer

Professor of Endocrinology and Geriatrics at the TU Dresden

Born in Bavaria, he has been Director of the Interdisciplinary Center for Healthy Aging at the University Hospital Carl Gustav Carus Dresden and Head of the Department of Endocrinology, Diabetes and Bone Diseases since 2015. At the same time, he holds the W3 professorship for internal medicine with a focus on geriatric medicine and endocrinology. Before that, his professional career took him to the Center for Internal Medicine at the Phillips University in Marburg (1999-2007), where he received recognition as a specialist in internal medicine, endocrinology and diabetology and as a sports physician. In 2002, Prof. Hofbauer habilitated in the subject of internal medicine, after obtaining his doctorate in 1995. medical graduated. He laid the cornerstone of his medical training between 1988 and 1994 while studying human medicine at the Ludwig-Maximilians-University in Munich, which was accompanied by several stays abroad in the USA, France and Japan. From 1996-1999 Hofbauer worked at the Mayo Clinic in Rochester (USA). Prof. Hofbauer has already received several awards for his research activities, he coordinates various national and European research consortia and has over 350 scientific publications and two patents. His scientific topics range from "diabetes and bones" and "bone metastases" to "new therapies against osteoporosis" to "mobility in old age".

Visit website: https://www.digs-bb.de/research/research-groups/lorenz-hofbauer

 lorenz-c-hofbauer-46a841223

See also: Academia TU Dresden (University of Technology) - Engineering sciences university in Germany

Details last updated 04-May-2023

Lorenz Hofbauer News

Revolutionary bio-inspired molecules accelerate bone healing: a breakthrough for regenerative medicine

Revolutionary bio-inspired molecules accelerate bone healing: a breakthrough for regenerative medicine

TU Dresden (University of Technology) - 28-Apr-2023

Novel molecules enhance bone regeneration in mice by 50%, paving the way for treatments for bone fractures and related conditions